Tirzepatide liver-fat and body-composition MRI substudy SURPASS-3, relative liver-fat reduction -29.8/-39.6/-47.1% at 5/10/15 mg vs insulin degludec -11.2%: Gastaldelli Lancet D&E 2022
GHK-Cu has the larger published research base over 100 published studies spanning five decades
(December 2013)
A: Yes, when prescribed by a licensed medical provider for legitimate medical purposes, peptides are legal and FDA-approved for various uses
Researchers studying musculoskeletal biology have been particularly interested in the BPC 157 5mg peptide for its apparent effects on tendon-to-bone healing, ligament repair models, and muscle crush injuries in rodent subjects
This is the most common question and the answer from a mechanistic standpoint is yes, they are complementary rather than redundant : BPC-157 works through nitric oxide and growth factors (gut-mediated) TB-500 works through actin mobilization and cell migration (structural) These are non-overlapping pathways, which is the theoretical basis for combining them
